US Stock MarketDetailed Quotes

RDY Dr Reddy's Laboratories Ltd

Watchlist
  • 74.420
  • -0.130-0.17%
Close Apr 29 16:00 ET
  • 74.420
  • 0.0000.00%
Post 17:31 ET
12.39BMarket Cap19.81P/E (TTM)

Dr Reddy's Laboratories Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-79.63%4.74B
93.15%17.93B
69.05%11.25B
109.46%58.88B
3,218.55%19.68B
-10.04%23.26B
81.77%9.28B
293.01%6.66B
-21.27%28.11B
-94.74%593M
Net income from continuing operations
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
108.06%11.88B
36.72%23.57B
-75.86%875M
Operating gains losses
250.53%286M
-135.23%-1.1B
83.40%-605M
57.46%-1.1B
14.89%-400M
-30.14%-190M
330.27%3.13B
-496.56%-3.65B
-282.51%-2.59B
-379.76%-470M
Depreciation and amortization
15.26%3.77B
21.21%3.79B
17.02%3.57B
6.87%12.64B
7.81%3.19B
9.91%3.27B
4.72%3.13B
4.99%3.05B
-7.60%11.82B
-6.66%2.96B
Deferred tax
15.30%4.47B
-13.02%4.33B
59.70%4.44B
75.26%15.3B
127.80%3.66B
46.56%3.88B
80.48%4.98B
61.85%2.78B
-4.85%8.73B
-36.59%1.61B
Other non cash items
-230.34%-189M
-493.55%-366M
-67.69%42M
3,642.86%248M
-101.40%-120M
101.69%145M
3,200.00%93M
912.50%130M
-104.86%-7M
6,453.44%8.59B
Change In working capital
-354.13%-11.86B
123.12%2.61B
-4.77%-8.17B
57.54%-7.86B
144.81%6.57B
-69.27%4.67B
-62.50%-11.29B
35.38%-7.8B
-72.59%-18.5B
-2,485.54%-14.66B
-Change in receivables
-561.61%-8.83B
297.68%7.34B
27.83%-4.65B
66.19%-5.75B
159.98%2.49B
-68.98%1.91B
50.86%-3.71B
43.91%-6.44B
-917.49%-17.01B
-213.44%-4.15B
-Change in inventory
-216.68%-5.2B
-471.70%-4.7B
-115.22%-4.64B
73.22%-2.65B
99.15%-121M
-119.21%-1.64B
18.11%1.27B
59.79%-2.16B
20.08%-9.91B
-291.03%-14.18B
-Change in payables and accrued expense
-85.88%390M
228.65%2.34B
516.48%2.22B
-99.48%23M
-138.59%-384M
282.14%2.76B
-1,339.46%-1.82B
-111.16%-534M
54.21%4.41B
182.92%995M
-Change in other working capital
9.25%1.78B
66.25%-2.37B
-183.94%-1.11B
-86.85%528M
72.16%4.59B
-17.65%1.63B
-1,046.90%-7.02B
6,127.27%1.33B
223.20%4.01B
341.23%2.67B
Cash from discontinued investing activities
Operating cash flow
-79.63%4.74B
93.15%17.93B
69.05%11.25B
109.46%58.88B
115.80%19.68B
34.21%23.26B
81.77%9.28B
293.01%6.66B
-21.27%28.11B
-19.06%9.12B
Investing cash flow
Cash flow from continuing investing activities
38.74%-16.18B
-178.79%-4.52B
-67.30%-8.24B
-56.79%-41.37B
28.27%-15.77B
-856.54%-26.41B
44.44%5.73B
12.20%-4.92B
-16.45%-26.39B
-132.68%-21.99B
Capital expenditure reported
-62.70%-5.04B
-18.32%-3.94B
-40.06%-12.17B
0.96%-18.87B
6.93%-3.75B
30.73%-3.1B
53.83%-3.33B
-160.41%-8.69B
-51.65%-19.05B
-25.73%-4.03B
Net PPE purchase and sale
6,450.00%524M
457.25%468M
-89.39%19M
-77.84%82M
-85.47%26M
-78.38%8M
-222.43%-131M
280.85%179M
335.29%370M
517.24%179M
Net intangibles purchase and sale
--0
----
----
--0
--0
--0
----
----
--2.95B
--0
Net business purchase and sale
----
----
----
--0
--0
----
----
----
97.90%-326M
----
Net investment purchase and sale
49.05%-11.96B
-119.68%-1.75B
1.43%3.56B
-108.61%-23.37B
31.87%-12.27B
-1,759.36%-23.48B
11.50%8.88B
236.54%3.51B
-372.53%-11.2B
-180.39%-18.02B
Cash from discontinued investing activities
Investing cash flow
38.74%-16.18B
-178.79%-4.52B
-67.30%-8.24B
-56.79%-41.37B
28.27%-15.77B
-856.54%-26.41B
44.44%5.73B
12.20%-4.92B
-16.45%-26.39B
-132.68%-21.99B
Financing cash flow
Cash flow from continuing financing activities
806.00%5.28B
43.01%-7.04B
86.33%-1.48B
-1,009.04%-26.86B
-184.32%-4.3B
122.70%583M
-71.19%-12.35B
-577.66%-10.8B
-712.75%-2.42B
-41.01%5.1B
Net issuance payments of debt
431.54%5.82B
91.70%-587M
90.37%-991M
-845.78%-20.4B
-176.45%-4.13B
149.80%1.09B
-141.66%-7.07B
-518.97%-10.29B
-55.12%2.74B
-45.70%5.4B
Net common stock issuance
-88.89%9M
1,860.00%686M
154.84%79M
10.18%368M
2,662.50%221M
80.00%81M
-73.88%35M
-78.91%31M
136.15%334M
100.81%8M
Cash dividends paid
--0
-33.52%-6.65B
--0
-20.09%-4.98B
--0
--0
-20.09%-4.98B
--0
0.02%-4.15B
--0
Cash from discontinued financing activities
Financing cash flow
806.00%5.28B
43.01%-7.04B
86.33%-1.48B
-1,009.04%-26.86B
-184.32%-4.3B
122.70%583M
-71.19%-12.35B
-577.66%-10.8B
-712.75%-2.42B
-41.01%5.1B
Net cash flow
Beginning cash position
48.85%13.54B
14.78%7.23B
-61.09%5.78B
0.22%14.85B
-71.52%6.26B
-8.89%9.09B
-22.91%6.3B
0.22%14.85B
655.35%14.82B
408.59%21.98B
Current changes in cash
-140.01%-6.16B
138.87%6.37B
116.96%1.54B
-1,235.09%-9.36B
94.96%-392M
-121.39%-2.57B
43.21%2.67B
-33.47%-9.07B
-105.50%-701M
-174.33%-7.77B
Effect of exchange rate changes
160.30%161M
-151.56%-66M
-117.35%-89M
-60.98%286M
-113.58%-88M
-4,350.00%-267M
350.98%128M
261.27%513M
548.67%733M
1,406.98%648M
End cash Position
20.39%7.54B
48.85%13.54B
14.78%7.23B
-61.09%5.78B
-61.09%5.78B
-71.52%6.26B
-8.89%9.09B
-22.91%6.3B
0.22%14.85B
0.22%14.85B
Free cash flow
-101.51%-305M
135.00%13.99B
54.74%-921M
341.65%40.01B
212.86%15.93B
56.81%20.16B
382.76%5.95B
70.01%-2.04B
-60.85%9.06B
-36.85%5.09B
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -79.63%4.74B93.15%17.93B69.05%11.25B109.46%58.88B3,218.55%19.68B-10.04%23.26B81.77%9.28B293.01%6.66B-21.27%28.11B-94.74%593M
Net income from continuing operations 10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B108.06%11.88B36.72%23.57B-75.86%875M
Operating gains losses 250.53%286M-135.23%-1.1B83.40%-605M57.46%-1.1B14.89%-400M-30.14%-190M330.27%3.13B-496.56%-3.65B-282.51%-2.59B-379.76%-470M
Depreciation and amortization 15.26%3.77B21.21%3.79B17.02%3.57B6.87%12.64B7.81%3.19B9.91%3.27B4.72%3.13B4.99%3.05B-7.60%11.82B-6.66%2.96B
Deferred tax 15.30%4.47B-13.02%4.33B59.70%4.44B75.26%15.3B127.80%3.66B46.56%3.88B80.48%4.98B61.85%2.78B-4.85%8.73B-36.59%1.61B
Other non cash items -230.34%-189M-493.55%-366M-67.69%42M3,642.86%248M-101.40%-120M101.69%145M3,200.00%93M912.50%130M-104.86%-7M6,453.44%8.59B
Change In working capital -354.13%-11.86B123.12%2.61B-4.77%-8.17B57.54%-7.86B144.81%6.57B-69.27%4.67B-62.50%-11.29B35.38%-7.8B-72.59%-18.5B-2,485.54%-14.66B
-Change in receivables -561.61%-8.83B297.68%7.34B27.83%-4.65B66.19%-5.75B159.98%2.49B-68.98%1.91B50.86%-3.71B43.91%-6.44B-917.49%-17.01B-213.44%-4.15B
-Change in inventory -216.68%-5.2B-471.70%-4.7B-115.22%-4.64B73.22%-2.65B99.15%-121M-119.21%-1.64B18.11%1.27B59.79%-2.16B20.08%-9.91B-291.03%-14.18B
-Change in payables and accrued expense -85.88%390M228.65%2.34B516.48%2.22B-99.48%23M-138.59%-384M282.14%2.76B-1,339.46%-1.82B-111.16%-534M54.21%4.41B182.92%995M
-Change in other working capital 9.25%1.78B66.25%-2.37B-183.94%-1.11B-86.85%528M72.16%4.59B-17.65%1.63B-1,046.90%-7.02B6,127.27%1.33B223.20%4.01B341.23%2.67B
Cash from discontinued investing activities
Operating cash flow -79.63%4.74B93.15%17.93B69.05%11.25B109.46%58.88B115.80%19.68B34.21%23.26B81.77%9.28B293.01%6.66B-21.27%28.11B-19.06%9.12B
Investing cash flow
Cash flow from continuing investing activities 38.74%-16.18B-178.79%-4.52B-67.30%-8.24B-56.79%-41.37B28.27%-15.77B-856.54%-26.41B44.44%5.73B12.20%-4.92B-16.45%-26.39B-132.68%-21.99B
Capital expenditure reported -62.70%-5.04B-18.32%-3.94B-40.06%-12.17B0.96%-18.87B6.93%-3.75B30.73%-3.1B53.83%-3.33B-160.41%-8.69B-51.65%-19.05B-25.73%-4.03B
Net PPE purchase and sale 6,450.00%524M457.25%468M-89.39%19M-77.84%82M-85.47%26M-78.38%8M-222.43%-131M280.85%179M335.29%370M517.24%179M
Net intangibles purchase and sale --0----------0--0--0----------2.95B--0
Net business purchase and sale --------------0--0------------97.90%-326M----
Net investment purchase and sale 49.05%-11.96B-119.68%-1.75B1.43%3.56B-108.61%-23.37B31.87%-12.27B-1,759.36%-23.48B11.50%8.88B236.54%3.51B-372.53%-11.2B-180.39%-18.02B
Cash from discontinued investing activities
Investing cash flow 38.74%-16.18B-178.79%-4.52B-67.30%-8.24B-56.79%-41.37B28.27%-15.77B-856.54%-26.41B44.44%5.73B12.20%-4.92B-16.45%-26.39B-132.68%-21.99B
Financing cash flow
Cash flow from continuing financing activities 806.00%5.28B43.01%-7.04B86.33%-1.48B-1,009.04%-26.86B-184.32%-4.3B122.70%583M-71.19%-12.35B-577.66%-10.8B-712.75%-2.42B-41.01%5.1B
Net issuance payments of debt 431.54%5.82B91.70%-587M90.37%-991M-845.78%-20.4B-176.45%-4.13B149.80%1.09B-141.66%-7.07B-518.97%-10.29B-55.12%2.74B-45.70%5.4B
Net common stock issuance -88.89%9M1,860.00%686M154.84%79M10.18%368M2,662.50%221M80.00%81M-73.88%35M-78.91%31M136.15%334M100.81%8M
Cash dividends paid --0-33.52%-6.65B--0-20.09%-4.98B--0--0-20.09%-4.98B--00.02%-4.15B--0
Cash from discontinued financing activities
Financing cash flow 806.00%5.28B43.01%-7.04B86.33%-1.48B-1,009.04%-26.86B-184.32%-4.3B122.70%583M-71.19%-12.35B-577.66%-10.8B-712.75%-2.42B-41.01%5.1B
Net cash flow
Beginning cash position 48.85%13.54B14.78%7.23B-61.09%5.78B0.22%14.85B-71.52%6.26B-8.89%9.09B-22.91%6.3B0.22%14.85B655.35%14.82B408.59%21.98B
Current changes in cash -140.01%-6.16B138.87%6.37B116.96%1.54B-1,235.09%-9.36B94.96%-392M-121.39%-2.57B43.21%2.67B-33.47%-9.07B-105.50%-701M-174.33%-7.77B
Effect of exchange rate changes 160.30%161M-151.56%-66M-117.35%-89M-60.98%286M-113.58%-88M-4,350.00%-267M350.98%128M261.27%513M548.67%733M1,406.98%648M
End cash Position 20.39%7.54B48.85%13.54B14.78%7.23B-61.09%5.78B-61.09%5.78B-71.52%6.26B-8.89%9.09B-22.91%6.3B0.22%14.85B0.22%14.85B
Free cash flow -101.51%-305M135.00%13.99B54.74%-921M341.65%40.01B212.86%15.93B56.81%20.16B382.76%5.95B70.01%-2.04B-60.85%9.06B-36.85%5.09B
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg